(en) R. Gniadecki, C. Assaf, M. Bagot, et al., « The optimal use of bexarotene in cutaneous T-cell lymphoma », Br. J. Dermatol., vol. 157, no 3, , p. 433–40 (PMID17553039, DOI10.1111/j.1365-2133.2007.07975.x)
(en) K. H. Dragnev, W. J. Petty, S. J. Shah, et al., « A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer », Clin. Cancer Res., vol. 13, no 6, , p. 1794–800 (PMID17363535, DOI10.1158/1078-0432.CCR-06-1836)
nih.gov
ncbi.nlm.nih.gov
(en) R. Gniadecki, C. Assaf, M. Bagot, et al., « The optimal use of bexarotene in cutaneous T-cell lymphoma », Br. J. Dermatol., vol. 157, no 3, , p. 433–40 (PMID17553039, DOI10.1111/j.1365-2133.2007.07975.x)
(en) K. H. Dragnev, W. J. Petty, S. J. Shah, et al., « A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer », Clin. Cancer Res., vol. 13, no 6, , p. 1794–800 (PMID17363535, DOI10.1158/1078-0432.CCR-06-1836)